These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 18685119)

  • 1. Does preoperative somatostatin analog treatment improve surgical cure rates in acromegaly? A new look at an old question.
    Beckers A
    J Clin Endocrinol Metab; 2008 Aug; 93(8):2975-7. PubMed ID: 18685119
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial.
    Carlsen SM; Lund-Johansen M; Schreiner T; Aanderud S; Johannesen O; Svartberg J; Cooper JG; Hald JK; Fougner SL; Bollerslev J;
    J Clin Endocrinol Metab; 2008 Aug; 93(8):2984-90. PubMed ID: 18492760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide as primary therapy for acromegaly.
    Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective treatment of recurrent acromegaly with a long-active somatostatin analogue (sandostatin).
    Miranda R; Zárate A; Ruíz Velasco G
    Arch Invest Med (Mex); 1988; 19(4):445-8. PubMed ID: 3245759
    [No Abstract]   [Full Text] [Related]  

  • 5. Six-month preoperative octreotide treatment in unselected, de novo patients with acromegaly: effect on biochemistry, tumour volume, and postoperative cure.
    Carlsen SM; Svartberg J; Schreiner T; Aanderud S; Johannesen O; Skeie S; Lund-Johansen M; Fougner SL; Bollerslev J;
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):736-43. PubMed ID: 21521254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly.
    Ben-Shlomo A; Melmed S
    J Clin Endocrinol Metab; 2003 Mar; 88(3):963-8. PubMed ID: 12629068
    [No Abstract]   [Full Text] [Related]  

  • 7. Predicting therapeutic response and degree of pituitary tumour shrinkage during treatment of acromegaly with octreotide LAR.
    Jenkins PJ; Emery M; Howling SJ; Evanson J; Besser GM; Monson JP
    Horm Res; 2004; 62(5):227-32. PubMed ID: 15477693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?
    Jallad RS; Musolino NR; Kodaira S; Cescato VA; Bronstein MD
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):310-5. PubMed ID: 17555503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of cardiac function after treatment with octreotide followed by trans-sphenoidal surgery in an acromegalic patient who presented with congestive heart failure.
    Shimakura A; Miyakoshi H; Ohkuwa H; Kitabayashi M; Komai T; Hisada A; Aoki K; Sakagami S; Kobayashi K; Takata S
    Jpn Heart J; 2002 Jan; 43(1):69-77. PubMed ID: 12041892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin analogs in the treatment of acromegaly.
    Lamberts SW; Reubi JC; Krenning EP
    Endocrinol Metab Clin North Am; 1992 Sep; 21(3):737-52. PubMed ID: 1355729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide treatment of acromegaly during pregnancy.
    Mikhail N
    Mayo Clin Proc; 2002 Mar; 77(3):297-8. PubMed ID: 11888040
    [No Abstract]   [Full Text] [Related]  

  • 12. Effective clinical response to long term octreotide treatment, with reduced serum concentrations of growth hormone, insulin-like growth factor-I, and the amino-terminal propeptide of type III procollagen in acromegaly.
    Salmela PI; Juustila H; Pyhtinen J; Jokinen K; Alavaikko M; Ruokonen A
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1193-201. PubMed ID: 2180976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group.
    Vance ML; Harris AG
    Arch Intern Med; 1991 Aug; 151(8):1573-8. PubMed ID: 1872661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy in persistent acromegaly.
    Hierl T; Ziegler R; Kasperk C
    Clin Endocrinol (Oxf); 2000 Aug; 53(2):262-3. PubMed ID: 10931109
    [No Abstract]   [Full Text] [Related]  

  • 15. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Plöckinger U; Quabbe HJ
    Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid progression of amyotrophic lateral sclerosis in an acromegalic patient after surgical resection of a growth hormone-producing pituitary adenoma.
    Mondok A; Aranyi Z; Kovacs GG; Czirjak S; Pusztai P; Varga I; Racz K
    Neurologist; 2010 Sep; 16(5):315-8. PubMed ID: 20827122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogues.
    Wass J
    Eur J Endocrinol; 2005 May; 152(5):693-4. PubMed ID: 15879353
    [No Abstract]   [Full Text] [Related]  

  • 18. Acromegaly and its treatment.
    Lamberts SW
    J Endocrinol; 1997 Oct; 155 Suppl 1():S49-51; discussion S67-71. PubMed ID: 9389995
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of somatostatin analogs on biochemical parameters in acromegaly.
    Liuzzi A; Marzullo P
    J Endocrinol Invest; 2003; 26(8 Suppl):46-9. PubMed ID: 15233212
    [No Abstract]   [Full Text] [Related]  

  • 20. Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly.
    Quabbe HJ; Plöckinger U
    J Clin Endocrinol Metab; 1989 May; 68(5):873-81. PubMed ID: 2565912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.